Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome (Review)

International Journal of Oncology

Volumn 41, Issue 3, 2012, Pages 793-797

  Banno, Kouji ^a   Kisu, Iori ^a   Yanokura, Megumi ^a   Tsuji, Kosuke ^a   Masuda, Kenta ^a   Ueki, Arisa ^a   Kobayashi, Yusuke ^a   Yamagami, Wataru ^a   Nomura, Hiroyuki ^a   Tominaga, Eiichiro ^a   Susumu, Nobuyuki ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Epimutation; Epithelial cell adhesion molecule; Human MutL homologue 1; Human MutS homologue 2; Lynch syndrome

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; HOMEODOMAIN PROTEIN; PROTEIN MLH1; PROTEIN MSH2; SOMATOMEDIN B;

ALLELE; ALPHA THALASSEMIA; BECKWITH WIEDEMANN SYNDROME; CANCER GROWTH; CANCER SUSCEPTIBILITY; COCARCINOGENESIS; DNA METHYLATION; EMBRYO DEVELOPMENT; EPIGENETICS; EPIMUTATION; FAMILIAL CANCER; GENE MUTATION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; RETINOBLASTOMA; REVIEW; SILVER RUSSELL SYNDROME; SOMATIC CELL;

CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GERM-LINE MUTATION; HUMANS; MUTATION; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84865007337     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1528     Document Type: Review

References (45)

1. Holliday R: The inheritance of epigenetic defects. Science 238: 163-170, 1987.
2. Das OP and Messing J: Variegated phenotype and developmental methylation changes of a maize allele originating from epimutation. Genetics 136: 1121-1141, 1994. (Pubitemid 24085659)
3. Schofield PN, Joyce JA, Lam WK, Grandjean V, Ferguson-Smith A, Reik W and Maher ER: Genomic imprinting and cancer; new paradigms in the genetics of neoplasia. Toxicol Lett 120: 151-160, 2001. (Pubitemid 32375081)
4. Hitchins M, Williams R, Cheong K, et al: MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology 129: 1392-1399, 2005. (Pubitemid 41597381)
5. Hitchins MP, Wong JJ, Suthers G, Suter CM, Martin DI, Hawkins NJ and Ward RL: Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 356: 697-705, 2007.
6. Valle L, Carbonell P, Fernandez V, Dotor AM, Sanz M, Benitez J and Urioste M: MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer. Clin Genet 71: 232-237, 2007. (Pubitemid 46322661)
7. Morak M, Schackert HK, Rahner N, et al: Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC. Eur J Hum Genet 16: 804-811, 2008. (Pubitemid 351865678)
8. Hitchins MP and Ward RL: Erasure of MLH1 methylation in spermatozoa-implications for epigenetic inheritance. Nat Genet 39: 1289, 2007. (Pubitemid 350035008)
9. Cooper WN, Luharia A, Evans GA, et al: Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 13: 1025-1032, 2005. (Pubitemid 43073609)
10. Schönherr N, Meyer E, Roos A, Schmidt A, Wollmann HA and Eggermann T: The centromeric 11p15 imprinting centre is also involved in Silver-Russell syndrome. J Med Genet 44: 59-63, 2007. (Pubitemid 46142840)
11. Conrad DF, Pinto D, Redon R, et al: Origins and functional impact of copy number variation in the human genome. Nature 464: 704-712, 2010.
12. Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, Wood WG and Higgs DR: Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 34: 157-165, 2003. (Pubitemid 36666926)
13. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM and Dryja TP: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646, 1986. (Pubitemid 16008560)
14. Nishisho I, Nakamura Y, Miyoshi Y, et al: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669, 1991. (Pubitemid 21917200)
15. Hussussian CJ, Struewing JP, Goldstein AM, et al: Germline p16 mutations in familial melanoma. Nat Genet 8: 15-21, 1994. (Pubitemid 24274055)
16. Greger V, Passarge E, Höpping W, Messmer E and Horsthemke B: Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83: 155-158, 1989.
17. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM and Dryja TP: Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48: 880-888, 1991. (Pubitemid 21891632)
18. Herman JG, Latif F, Weng Y, et al: Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704, 1994. (Pubitemid 24311875)
19. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57: 808-811, 1997. (Pubitemid 27097998)
20. Dobrovic A and Simpfendorfer D: Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57: 3347-3350, 1997. 21. de la Chapelle A: Genetic predisposition to human disease: allele-specific expression and low-penetrance regulatory loci. Oncogene 28: 3345-3348, 2009.
21. Weisenberger DJ, Siegmund KD, Campan M, et al: CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793, 2006. (Pubitemid 43980599)
22. Gazzoli I, Loda M, Garber J, Syngal S and Kolodner RD: A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 62: 3925-3928, 2002. (Pubitemid 34791053)
23. Suter CM, Martin DI and Ward RL: Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 36: 497-501, 2004. (Pubitemid 38620035)
24. Miyakura Y, Sugano K, Konishi F, et al: Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology 121: 1300-1309, 2001. (Pubitemid 33140447)
25. Miyakura Y, Sugano K, Konishi F, et al: Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis. Genes Chromosomes Cancer 36: 17-25, 2003. (Pubitemid 36077378)
26. Miyakura Y, Sugano K, Akasu T, et al: Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin Gastroenterol Hepatol 2: 147-156, 2004. (Pubitemid 38180469)
27. Chan TL, Yuen ST, Kong CK, et al: Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 38: 1178-1183, 2006. (Pubitemid 44470364)
28. Raval A, Tanner SM, Byrd JC, et al: Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129: 879-890, 2007. (Pubitemid 46813150)
29. Reddy AN, Jiang WW, Kim M, Benoit N, Taylor R, Clinger J, Sidransky D and Califano JA: Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res 63: 7694-7698, 2003. (Pubitemid 37466698)
30. Armes JE and Venter DJ: The pathology of inherited breast cancer. Pathology 34: 309-314, 2002. (Pubitemid 34827990)
31. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, MaGuffog L and Easton DF: The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20: 2310-2318, 2002. (Pubitemid 34441658)
32. Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M and Akslen LA: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95: 1482-1485, 2003. (Pubitemid 37279334)
33. Esteller M, Silva JM, Dominguez G, et al: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92: 564-569, 2000. (Pubitemid 30212318)
34. Catteau A and Morris JR: BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol 12: 359-371, 2002.
35. Hedenfalk I, Duggan D, Chen Y, et al: Gene-expression profiles in hereditary breast cancer. N Engl J Med 344: 539-548, 2001. (Pubitemid 32167867)
36. Snell C, Krypuy M, Wong EM; kConFab investigators, Loughrey MB and Dobrovic A: BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res 10: R12, 2008.
37. Hampel H, Frankel WL, Martin E, et al: Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26: 5783-5788, 2008.
38. Peltomäki P and Vasen H: Mutations associated with HNPCC predisposition - Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20: 269-276, 2004. (Pubitemid 40164099)
39. Hirata K, Kanemitsu S, Nakayama Y, Nagata N, Itoh H, Ohnishi H, Ishikawa H and Furukawa Y; HNPCC registry and genetic testing project of the Japanese Society for Cancer of the Colon and Rectum (JSCCR): A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma. Am J Gastroenterol 101: 193-196, 2006.
40. Naruse H, Ikawa N, Yamaguchi K, et al: Determination of splice-site mutations in Lynch syndrome (hereditary nonpolyposis colorectal cancer) patients using functional splicing assay. Fam Cancer 8: 509-517, 2009.
41. Winter MJ, Nagtegaal ID, van Krieken JH and Litvinov SV: The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 163: 2139-2148, 2003. (Pubitemid 37466457)
42. Ligtenberg MJ, Kuiper RP, Chan TL, et al: Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet 41: 112-117, 2009.
43. Fraga MF, Ballestar E, Paz MF, et al: Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102: 10604-10609, 2005. (Pubitemid 41061601)
44. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-540, 1994. (Pubitemid 24308343)
45. Rose MG: Hematology: azacitidine improves survival in myelodysplastic syndromes. Nat Rev Clin Oncol 6: 502-503, 2009.